DELCATH SYSTEMS, INC.

Profile

Company Names

DELCATH SYSTEMS, INC.

Addresses

566 QUEENSBURY AVENUE, QUEENSBURY, NY 12804

1633 BROADWAY, SUITE 22C, NEW YORK, NY 10019

1633 BROADWAY, SUITE 22C, NEW YORK, NY 10019

1633 BROADWAY, NY, NY 10019

Phone Numbers

(518) 743-8892
(212) 489-2100
212-489-2100

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$71,919,044.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2024-03-19 
$7,001,113.00 
$7,001,113.00 
$0.00 
Equity 
6
2023-03-29 
$24,999,999.00 
$24,999,999.00 
$0.00 
Equity 
5
2022-12-12 
$3,807,499.00 
$3,807,499.00 
$0.00 
Equity 
4
2022-07-20 
$4,999,999.00 
$4,999,999.00 
$0.00 
Equity 
3
2019-08-19 
$9,510,434.00 
$9,510,434.00 
$0.00 
Equity 
2
2019-07-15 
$20,000,000.00 
$20,000,000.00 
$0.00 
Equity 
1
2018-07-20 
$1,600,000.00 
$1,600,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GILAD 
 
AHARON 
DIRECTOR
ELIZABETH 
 
CZEREPAK 
DIRECTOR
ANTHONY 
 
DIAS 
EXECUTIVE OFFICER
DAVID 
J. 
HOFFMAN 
EXECUTIVE OFFICER
JOHNNY 
 
JOHN 
EXECUTIVE OFFICER
BARBRA 
 
KECK 
EXECUTIVE OFFICER
BARBRA 
KECK 
EXECUTIVE OFFICER
GERARD 
 
MICHEL 
EXECUTIVE OFFICER, DIRECTOR
KEVIN 
 
MUIR 
EXECUTIVE OFFICER
SANDRA 
 
PENNELL 
EXECUTIVE OFFICER
JOHN 
 
PURPURA 
EXECUTIVE OFFICER
MARTHA 
 
ROOK 
EXECUTIVE OFFICER
WILLIAM 
 
RUECKERT 
DIRECTOR
WILLIAM 
RUECKERT 
DIRECTOR
STEVEN 
 
SALAMON 
DIRECTOR
JENNIFER 
 
SIMPSON 
EXECUTIVE OFFICER, DIRECTOR
JENNIFER 
SIMPSON 
EXECUTIVE OFFICER, DIRECTOR
ROGER 
 
STOLL 
DIRECTOR
ROGER 
STOLL 
DIRECTOR
ROGER 
G. 
STOLL 
DIRECTOR
JOHN 
SYLVESTER 
DIRECTOR
JOHN 
R. 
SYLVESTER 
DIRECTOR
MARCO 
 
TAGLIETTI 
DIRECTOR
VOJO 
 
VUKOVIC 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2024-03-19 
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2023-03-29 
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2022-12-12 
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2022-07-20 
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2019-08-19 
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2019-07-15 
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Debt 
2018-07-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
CANACCORD GENUITY CORP.
NONE
CANACCORD GENUITY LLC
NONE
NONE
ROTH CAPITAL PARTNERS, LLC
NONE
NONE
BTIG, LLC
NONE
NONE
ROTH CAPITAL PARTNERS, LLC
ADVISORY GROUP EQUITY SERVICES LTD.
NA
NONE
NONE
NONE
ROTH CAPITAL PARTNERS